In the present study, we used large cohorts of lung cancer patients derived from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) datasets to demonstrate the prognostic significance of pyrimidine metabolic rate–limiting enzymes and purinergic receptors in LUAD. This evidence concerns the gene P2RY2 and lung cancer.